Loading…
Effect of tetramethylpyrazine on potassium channels to lower calcium concentration in cultured aortic smooth muscle cells
Summary 1. Tetramethylpyrazine (TMP) is one of the active principles contained in Ligusticum chuanxiong Hort. (Umbelliferae), a herb that has been used widely in China to treat vascular disorders. 2. In an attempt to elucidate the possible mechanisms of action of TMP, the effect of TMP on intracellu...
Saved in:
Published in: | Clinical and experimental pharmacology & physiology 2003-10, Vol.30 (10), p.793-798 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4693-c2c9e4456c095bb3ee2233868199a148edbb8e976195a43417b825d54c6ea0653 |
---|---|
cites | cdi_FETCH-LOGICAL-c4693-c2c9e4456c095bb3ee2233868199a148edbb8e976195a43417b825d54c6ea0653 |
container_end_page | 798 |
container_issue | 10 |
container_start_page | 793 |
container_title | Clinical and experimental pharmacology & physiology |
container_volume | 30 |
creator | Wong, Kar-Lok Chan, Paul Huang, Wei-Chan Yang, Tzyy-Lin Liu, I-Min Lai, Tung-Yuan Tsai, Chin-Chuan Cheng, Juei-Tang |
description | Summary
1. Tetramethylpyrazine (TMP) is one of the active principles contained in Ligusticum chuanxiong Hort. (Umbelliferae), a herb that has been used widely in China to treat vascular disorders.
2. In an attempt to elucidate the possible mechanisms of action of TMP, the effect of TMP on intracellular calcium concentrations ([Ca2+]i) was investigated in cultured vascular smooth muscle (A7r5) cells using the Ca2+‐sensitive dye Fura‐2 as an indicator.
3. The increase in [Ca2+]i in A7r5 cells produced by vasopressin (1 µmol/L) or phenylephrine (1 µmol/L) was attenuated by TMP in a concentration‐dependent manner. Only inhibitors specific to ATP‐sensitive potassium (KATP) channels or small conductance calcium‐activated potassium (SKCa) channels attenuated the action of TMP (10 µmol/L) on [Ca2+]i. However, blockers of other K+ channels failed to modify the inhibitory action of TMP (10 µmol/L) on [Ca2+]i.
4. The action of TMP on membrane potential in A7r5 cells was monitored by the fluorescence of bisoxonol. Tetramethylpyrazine caused a concentration‐dependent inhibition of changes in membrane potential elicited by KCl (20 mmol/L) or phenylephrine (1 µmol/L), an effect that was totally reversed by glibenclamide (100 µmol/L) and apamin (100 nmol/L) in combination.
5. The results obtained indicate that the decrease in [Ca2+]i in A7r5 cells produced by TMP is mediated mainly by opening of KATP and/or SKCa channels. |
doi_str_mv | 10.1046/j.1440-1681.2003.03913.x |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75724766</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>75724766</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4693-c2c9e4456c095bb3ee2233868199a148edbb8e976195a43417b825d54c6ea0653</originalsourceid><addsrcrecordid>eNqNkE2P0zAQhi0EYsvCX0A-cUvwd5IDB1TKdqUVcADt0XLcierixMV2tA2_nmRbLdc9jaV5n5nxgxCmpKREqI-HkgpBCqpqWjJCeEl4Q3l5eoFWT42XaEU4kQWtK3KF3qR0IIRIovhrdEWFpEowskLTpuvAZhw6nCFH00PeT_44RfPXDYDDgI8hm5Tc2GO7N8MAPuEcsA8PELE13j52wmBhmPHsZsIN2I4-jxF22ISYncWpDyHvcT8m6wFb8D69Ra864xO8u9Rr9Ovr5ud6W9x9v7ldf74rrFANLyyzDQghlSWNbFsOwBjn9fzBpjFU1LBr2xqaStFGGsEFrdqayZ0UVoEhSvJr9OE89xjDnxFS1r1LywVmgDAmXcmKiUqpOVifgzaGlCJ0-hhdb-KkKdGLdn3Qi1292NWLdv2oXZ9m9P1lx9j2sPsPXjzPgU_nwIPzMD17sF5vfiyvmS_OvEsZTk-8ib-1qngl9f23G_1lxtl2y_Q9_wc2m6Hq</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75724766</pqid></control><display><type>article</type><title>Effect of tetramethylpyrazine on potassium channels to lower calcium concentration in cultured aortic smooth muscle cells</title><source>Wiley-Blackwell Read & Publish Collection</source><source>SPORTDiscus with Full Text</source><creator>Wong, Kar-Lok ; Chan, Paul ; Huang, Wei-Chan ; Yang, Tzyy-Lin ; Liu, I-Min ; Lai, Tung-Yuan ; Tsai, Chin-Chuan ; Cheng, Juei-Tang</creator><creatorcontrib>Wong, Kar-Lok ; Chan, Paul ; Huang, Wei-Chan ; Yang, Tzyy-Lin ; Liu, I-Min ; Lai, Tung-Yuan ; Tsai, Chin-Chuan ; Cheng, Juei-Tang</creatorcontrib><description>Summary
1. Tetramethylpyrazine (TMP) is one of the active principles contained in Ligusticum chuanxiong Hort. (Umbelliferae), a herb that has been used widely in China to treat vascular disorders.
2. In an attempt to elucidate the possible mechanisms of action of TMP, the effect of TMP on intracellular calcium concentrations ([Ca2+]i) was investigated in cultured vascular smooth muscle (A7r5) cells using the Ca2+‐sensitive dye Fura‐2 as an indicator.
3. The increase in [Ca2+]i in A7r5 cells produced by vasopressin (1 µmol/L) or phenylephrine (1 µmol/L) was attenuated by TMP in a concentration‐dependent manner. Only inhibitors specific to ATP‐sensitive potassium (KATP) channels or small conductance calcium‐activated potassium (SKCa) channels attenuated the action of TMP (10 µmol/L) on [Ca2+]i. However, blockers of other K+ channels failed to modify the inhibitory action of TMP (10 µmol/L) on [Ca2+]i.
4. The action of TMP on membrane potential in A7r5 cells was monitored by the fluorescence of bisoxonol. Tetramethylpyrazine caused a concentration‐dependent inhibition of changes in membrane potential elicited by KCl (20 mmol/L) or phenylephrine (1 µmol/L), an effect that was totally reversed by glibenclamide (100 µmol/L) and apamin (100 nmol/L) in combination.
5. The results obtained indicate that the decrease in [Ca2+]i in A7r5 cells produced by TMP is mediated mainly by opening of KATP and/or SKCa channels.</description><identifier>ISSN: 0305-1870</identifier><identifier>EISSN: 1440-1681</identifier><identifier>DOI: 10.1046/j.1440-1681.2003.03913.x</identifier><identifier>PMID: 14516420</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Pty</publisher><subject>Animals ; Aorta - cytology ; Aorta - drug effects ; Aorta - metabolism ; bisoxonol ; Calcium - antagonists & inhibitors ; Calcium - metabolism ; Cell Line ; cultured vascular smooth muscle cells ; Dose-Response Relationship, Drug ; Fura-2 ; intracellular calcium concentrations ; Muscle, Smooth, Vascular - cytology ; Muscle, Smooth, Vascular - drug effects ; Muscle, Smooth, Vascular - metabolism ; potassium channel blockers ; Potassium Channel Blockers - pharmacology ; Potassium Channels - metabolism ; Pyrazines - pharmacology ; Rats ; tetramethylpyrazine</subject><ispartof>Clinical and experimental pharmacology & physiology, 2003-10, Vol.30 (10), p.793-798</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4693-c2c9e4456c095bb3ee2233868199a148edbb8e976195a43417b825d54c6ea0653</citedby><cites>FETCH-LOGICAL-c4693-c2c9e4456c095bb3ee2233868199a148edbb8e976195a43417b825d54c6ea0653</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27911,27912</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14516420$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wong, Kar-Lok</creatorcontrib><creatorcontrib>Chan, Paul</creatorcontrib><creatorcontrib>Huang, Wei-Chan</creatorcontrib><creatorcontrib>Yang, Tzyy-Lin</creatorcontrib><creatorcontrib>Liu, I-Min</creatorcontrib><creatorcontrib>Lai, Tung-Yuan</creatorcontrib><creatorcontrib>Tsai, Chin-Chuan</creatorcontrib><creatorcontrib>Cheng, Juei-Tang</creatorcontrib><title>Effect of tetramethylpyrazine on potassium channels to lower calcium concentration in cultured aortic smooth muscle cells</title><title>Clinical and experimental pharmacology & physiology</title><addtitle>Clin Exp Pharmacol Physiol</addtitle><description>Summary
1. Tetramethylpyrazine (TMP) is one of the active principles contained in Ligusticum chuanxiong Hort. (Umbelliferae), a herb that has been used widely in China to treat vascular disorders.
2. In an attempt to elucidate the possible mechanisms of action of TMP, the effect of TMP on intracellular calcium concentrations ([Ca2+]i) was investigated in cultured vascular smooth muscle (A7r5) cells using the Ca2+‐sensitive dye Fura‐2 as an indicator.
3. The increase in [Ca2+]i in A7r5 cells produced by vasopressin (1 µmol/L) or phenylephrine (1 µmol/L) was attenuated by TMP in a concentration‐dependent manner. Only inhibitors specific to ATP‐sensitive potassium (KATP) channels or small conductance calcium‐activated potassium (SKCa) channels attenuated the action of TMP (10 µmol/L) on [Ca2+]i. However, blockers of other K+ channels failed to modify the inhibitory action of TMP (10 µmol/L) on [Ca2+]i.
4. The action of TMP on membrane potential in A7r5 cells was monitored by the fluorescence of bisoxonol. Tetramethylpyrazine caused a concentration‐dependent inhibition of changes in membrane potential elicited by KCl (20 mmol/L) or phenylephrine (1 µmol/L), an effect that was totally reversed by glibenclamide (100 µmol/L) and apamin (100 nmol/L) in combination.
5. The results obtained indicate that the decrease in [Ca2+]i in A7r5 cells produced by TMP is mediated mainly by opening of KATP and/or SKCa channels.</description><subject>Animals</subject><subject>Aorta - cytology</subject><subject>Aorta - drug effects</subject><subject>Aorta - metabolism</subject><subject>bisoxonol</subject><subject>Calcium - antagonists & inhibitors</subject><subject>Calcium - metabolism</subject><subject>Cell Line</subject><subject>cultured vascular smooth muscle cells</subject><subject>Dose-Response Relationship, Drug</subject><subject>Fura-2</subject><subject>intracellular calcium concentrations</subject><subject>Muscle, Smooth, Vascular - cytology</subject><subject>Muscle, Smooth, Vascular - drug effects</subject><subject>Muscle, Smooth, Vascular - metabolism</subject><subject>potassium channel blockers</subject><subject>Potassium Channel Blockers - pharmacology</subject><subject>Potassium Channels - metabolism</subject><subject>Pyrazines - pharmacology</subject><subject>Rats</subject><subject>tetramethylpyrazine</subject><issn>0305-1870</issn><issn>1440-1681</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNqNkE2P0zAQhi0EYsvCX0A-cUvwd5IDB1TKdqUVcADt0XLcierixMV2tA2_nmRbLdc9jaV5n5nxgxCmpKREqI-HkgpBCqpqWjJCeEl4Q3l5eoFWT42XaEU4kQWtK3KF3qR0IIRIovhrdEWFpEowskLTpuvAZhw6nCFH00PeT_44RfPXDYDDgI8hm5Tc2GO7N8MAPuEcsA8PELE13j52wmBhmPHsZsIN2I4-jxF22ISYncWpDyHvcT8m6wFb8D69Ra864xO8u9Rr9Ovr5ud6W9x9v7ldf74rrFANLyyzDQghlSWNbFsOwBjn9fzBpjFU1LBr2xqaStFGGsEFrdqayZ0UVoEhSvJr9OE89xjDnxFS1r1LywVmgDAmXcmKiUqpOVifgzaGlCJ0-hhdb-KkKdGLdn3Qi1292NWLdv2oXZ9m9P1lx9j2sPsPXjzPgU_nwIPzMD17sF5vfiyvmS_OvEsZTk-8ib-1qngl9f23G_1lxtl2y_Q9_wc2m6Hq</recordid><startdate>200310</startdate><enddate>200310</enddate><creator>Wong, Kar-Lok</creator><creator>Chan, Paul</creator><creator>Huang, Wei-Chan</creator><creator>Yang, Tzyy-Lin</creator><creator>Liu, I-Min</creator><creator>Lai, Tung-Yuan</creator><creator>Tsai, Chin-Chuan</creator><creator>Cheng, Juei-Tang</creator><general>Blackwell Science Pty</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200310</creationdate><title>Effect of tetramethylpyrazine on potassium channels to lower calcium concentration in cultured aortic smooth muscle cells</title><author>Wong, Kar-Lok ; Chan, Paul ; Huang, Wei-Chan ; Yang, Tzyy-Lin ; Liu, I-Min ; Lai, Tung-Yuan ; Tsai, Chin-Chuan ; Cheng, Juei-Tang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4693-c2c9e4456c095bb3ee2233868199a148edbb8e976195a43417b825d54c6ea0653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Animals</topic><topic>Aorta - cytology</topic><topic>Aorta - drug effects</topic><topic>Aorta - metabolism</topic><topic>bisoxonol</topic><topic>Calcium - antagonists & inhibitors</topic><topic>Calcium - metabolism</topic><topic>Cell Line</topic><topic>cultured vascular smooth muscle cells</topic><topic>Dose-Response Relationship, Drug</topic><topic>Fura-2</topic><topic>intracellular calcium concentrations</topic><topic>Muscle, Smooth, Vascular - cytology</topic><topic>Muscle, Smooth, Vascular - drug effects</topic><topic>Muscle, Smooth, Vascular - metabolism</topic><topic>potassium channel blockers</topic><topic>Potassium Channel Blockers - pharmacology</topic><topic>Potassium Channels - metabolism</topic><topic>Pyrazines - pharmacology</topic><topic>Rats</topic><topic>tetramethylpyrazine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wong, Kar-Lok</creatorcontrib><creatorcontrib>Chan, Paul</creatorcontrib><creatorcontrib>Huang, Wei-Chan</creatorcontrib><creatorcontrib>Yang, Tzyy-Lin</creatorcontrib><creatorcontrib>Liu, I-Min</creatorcontrib><creatorcontrib>Lai, Tung-Yuan</creatorcontrib><creatorcontrib>Tsai, Chin-Chuan</creatorcontrib><creatorcontrib>Cheng, Juei-Tang</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical and experimental pharmacology & physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wong, Kar-Lok</au><au>Chan, Paul</au><au>Huang, Wei-Chan</au><au>Yang, Tzyy-Lin</au><au>Liu, I-Min</au><au>Lai, Tung-Yuan</au><au>Tsai, Chin-Chuan</au><au>Cheng, Juei-Tang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of tetramethylpyrazine on potassium channels to lower calcium concentration in cultured aortic smooth muscle cells</atitle><jtitle>Clinical and experimental pharmacology & physiology</jtitle><addtitle>Clin Exp Pharmacol Physiol</addtitle><date>2003-10</date><risdate>2003</risdate><volume>30</volume><issue>10</issue><spage>793</spage><epage>798</epage><pages>793-798</pages><issn>0305-1870</issn><eissn>1440-1681</eissn><abstract>Summary
1. Tetramethylpyrazine (TMP) is one of the active principles contained in Ligusticum chuanxiong Hort. (Umbelliferae), a herb that has been used widely in China to treat vascular disorders.
2. In an attempt to elucidate the possible mechanisms of action of TMP, the effect of TMP on intracellular calcium concentrations ([Ca2+]i) was investigated in cultured vascular smooth muscle (A7r5) cells using the Ca2+‐sensitive dye Fura‐2 as an indicator.
3. The increase in [Ca2+]i in A7r5 cells produced by vasopressin (1 µmol/L) or phenylephrine (1 µmol/L) was attenuated by TMP in a concentration‐dependent manner. Only inhibitors specific to ATP‐sensitive potassium (KATP) channels or small conductance calcium‐activated potassium (SKCa) channels attenuated the action of TMP (10 µmol/L) on [Ca2+]i. However, blockers of other K+ channels failed to modify the inhibitory action of TMP (10 µmol/L) on [Ca2+]i.
4. The action of TMP on membrane potential in A7r5 cells was monitored by the fluorescence of bisoxonol. Tetramethylpyrazine caused a concentration‐dependent inhibition of changes in membrane potential elicited by KCl (20 mmol/L) or phenylephrine (1 µmol/L), an effect that was totally reversed by glibenclamide (100 µmol/L) and apamin (100 nmol/L) in combination.
5. The results obtained indicate that the decrease in [Ca2+]i in A7r5 cells produced by TMP is mediated mainly by opening of KATP and/or SKCa channels.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Pty</pub><pmid>14516420</pmid><doi>10.1046/j.1440-1681.2003.03913.x</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0305-1870 |
ispartof | Clinical and experimental pharmacology & physiology, 2003-10, Vol.30 (10), p.793-798 |
issn | 0305-1870 1440-1681 |
language | eng |
recordid | cdi_proquest_miscellaneous_75724766 |
source | Wiley-Blackwell Read & Publish Collection; SPORTDiscus with Full Text |
subjects | Animals Aorta - cytology Aorta - drug effects Aorta - metabolism bisoxonol Calcium - antagonists & inhibitors Calcium - metabolism Cell Line cultured vascular smooth muscle cells Dose-Response Relationship, Drug Fura-2 intracellular calcium concentrations Muscle, Smooth, Vascular - cytology Muscle, Smooth, Vascular - drug effects Muscle, Smooth, Vascular - metabolism potassium channel blockers Potassium Channel Blockers - pharmacology Potassium Channels - metabolism Pyrazines - pharmacology Rats tetramethylpyrazine |
title | Effect of tetramethylpyrazine on potassium channels to lower calcium concentration in cultured aortic smooth muscle cells |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T17%3A49%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20tetramethylpyrazine%20on%20potassium%20channels%20to%20lower%20calcium%20concentration%20in%20cultured%20aortic%20smooth%20muscle%20cells&rft.jtitle=Clinical%20and%20experimental%20pharmacology%20&%20physiology&rft.au=Wong,%20Kar-Lok&rft.date=2003-10&rft.volume=30&rft.issue=10&rft.spage=793&rft.epage=798&rft.pages=793-798&rft.issn=0305-1870&rft.eissn=1440-1681&rft_id=info:doi/10.1046/j.1440-1681.2003.03913.x&rft_dat=%3Cproquest_cross%3E75724766%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4693-c2c9e4456c095bb3ee2233868199a148edbb8e976195a43417b825d54c6ea0653%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=75724766&rft_id=info:pmid/14516420&rfr_iscdi=true |